Salts of obicetrapib and processes for their manufacture and intermediates thereof
US12378221B2 · kind B2 · utility
0Cited by
9References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2024 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Apr 16, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is a method for the manufacture of a compound of obicetrapib and salts thereof, such as calcium salts thereof. Also provided herein is amorphous obicetrapib hemicalcium. New intermediates for use in the synthesis of obicetrapib, and salts thereof are also provided, including obicetrapib HCl and a mesylate salt for the use in the synthesis of obicetrapib and amorphous obicetrapib hemicalcium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.